Evidence map›Paper›PMID 26346523›Full record

ArticleBioMed research international2015

In Silico Identification of Highly Conserved Epitopes of Influenza A H1N1, H2N2, H3N2, and H5N1 with Diagnostic and Vaccination Potential.

José Esteban Muñoz-Medina, Carlos Javier Sánchez-Vallejo, Alfonso Méndez-Tenorio, Irma Eloísa Monroy-Muñoz, Javier Angeles-Martínez, Andrea Santos Coy-Arechavaleta, Clara Esperanza Santacruz-Tinoco, Joaquín González-Ibarra, Yu-Mei Anguiano-Hernández, César Raúl González-Bonilla and 2 more

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Pregnancy and pandemics: Interaction of viral surface proteins and placenta cells.Biochimica et biophysica acta. Molecular basis of disease · 2021
    Review
  9. Article
  10. Article
  11. Epitope-based vaccine as a universal vaccination strategy againstJournal of advanced veterinary and animal research · 2019
    Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

José Esteban Muñoz-MedinaLaboratorio Central de Epidemiología, Centro Médico Nacional La Raza, Instituto Mexicano del Seguro Social, Avenida Jacarandas S/N, Esquina Circuito Interior, Colonia La Raza Delegación Azcapotzalco, 02990 México, DF, Mexico.
Carlos Javier Sánchez-VallejoLaboratorio de Biotecnología y Bioinformática Genómica, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Carpio y Plan de Ayala S/N, Colonia Plutarco Elías Calles, Delegación Miguel Hidalgo, 11340 México, DF, Mexico.
Alfonso Méndez-TenorioLaboratorio de Biotecnología y Bioinformática Genómica, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Carpio y Plan de Ayala S/N, Colonia Plutarco Elías Calles, Delegación Miguel Hidalgo, 11340 México, DF, Mexico.
Irma Eloísa Monroy-MuñozLaboratorio de Genómica, Departamento de Genética y Genómica Humana, Instituto Nacional de Perinatología "Isidro Espinosa de los Reyes", Montes Urales 800, Colonia Lomas Virreyes, Delegación Miguel Hidalgo, 11000 México, DF, Mexico.
Javier Angeles-MartínezLaboratorio de Genómica, Departamento de Biología Molecular, Instituto Nacional de Cardiología "Ignacio Chávez", Juan Badiano No. 1, Colonia Sección XVI, Delegación Tlalpan, 14080 México, DF, Mexico.
Andrea Santos Coy-ArechavaletaLaboratorio Central de Epidemiología, Centro Médico Nacional La Raza, Instituto Mexicano del Seguro Social, Avenida Jacarandas S/N, Esquina Circuito Interior, Colonia La Raza Delegación Azcapotzalco, 02990 México, DF, Mexico.
Clara Esperanza Santacruz-TinocoLaboratorio Central de Epidemiología, Centro Médico Nacional La Raza, Instituto Mexicano del Seguro Social, Avenida Jacarandas S/N, Esquina Circuito Interior, Colonia La Raza Delegación Azcapotzalco, 02990 México, DF, Mexico.
Joaquín González-IbarraDivisión de Laboratorios de Vigilancia e Investigación Epidemiológica, Instituto Mexicano del Seguro Social, Mier y Pesado No. 120, Colonia Del Valle, Delegación Benito Juárez, 03100 México, DF, Mexico.
Yu-Mei Anguiano-HernándezLaboratorio Central de Epidemiología, Centro Médico Nacional La Raza, Instituto Mexicano del Seguro Social, Avenida Jacarandas S/N, Esquina Circuito Interior, Colonia La Raza Delegación Azcapotzalco, 02990 México, DF, Mexico.
César Raúl González-BonillaDivisión de Laboratorios de Vigilancia e Investigación Epidemiológica, Instituto Mexicano del Seguro Social, Mier y Pesado No. 120, Colonia Del Valle, Delegación Benito Juárez, 03100 México, DF, Mexico.
Eva Ramón-GallegosLaboratorio de Citopatologia Ambiental, Departamento de Morfología, Escuela Nacional de Ciencias Biológicas Campus Zacatenco, Instituto Politécnico Nacional, Wilfrido Massieu S/N, Colonia Nueva Industrial Vallejo, Delegación Gustavo A. Madero, 07738 México, DF, Mexico.
José Alberto Díaz-QuiñonezInstituto de Diagnóstico y Referencia Epidemiológicos "Manuel Martínez Báez", Francisco de P. Miranda No. 177, Colonia Unidad Lomas de Plateros, Delegación Álvaro Obregón, 01480 México, DF, Mexico ; Facultad de Medicina, Universidad Nacional Autónoma de México, Avenida Universidad 3000, Colonia Copilco Universidad, Delegación Coyoacán, 04510 México, DF, Mexico.
Mexican Social Security Institute · MXInstituto Politécnico Nacional · MXCentro Médico Nacional La Raza · MXInstituto Nacional de Cardiología · MXInstituto Nacional de Perinatología · MXSecretaria de Salud · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The unpredictable, evolutionary nature of the influenza A virus (IAV) is the primary problem when generating a vaccine and when designing diagnostic strategies; thus, it is necessary to determine the constant regions in viral proteins. In this study, we completed an in silico analysis of the reported epitopes of the 4 IAV proteins that are antigenically most significant (HA, NA, NP, and M2) in the 3 strains with the greatest world circulation in the last century (H1N1, H2N2, and H3N2) and in one of the main aviary subtypes responsible for zoonosis (H5N1). For this purpose, the HMMER program was used to align 3,016 epitopes reported in the Immune Epitope Database and Analysis Resource (IEDB) and distributed in 34,294 stored sequences in the Pfam database. Eighteen epitopes were identified: 8 in HA, 5 in NA, 3 in NP, and 2 in M2. These epitopes have remained constant since they were first identified (~91 years) and are present in strains that have circulated on 5 continents. These sites could be targets for vaccination design strategies based on epitopes and/or as markers in the implementation of diagnostic techniques.

Indexed as

EpitopesInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H2N2 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza A Virus, H5N1 SubtypeInfluenza VaccinesComputer SimulationHumansEpitopesInfluenza Vaccines

Identifiers

PMID26346523
PMCPMC4544958
OpenAlexW1497497378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.